Neoadjuvant PD-1 blockade in mismatch repair-deficient or microsatellite instability-high, locally advanced and resectable colorectal cancer: A retrospective real-world analysis. This is an ASCO ...

Recent studies have provided valuable insights into the molecular underpinnings of peritoneal metastases, particularly in colorectal cancer. One study identified that colorectal cancer-related ...

BRAF V600E-mutant metastatic colorectal cancer (CRC) was associated with poor clinical outcomes in patients receiving ...

Nelmastobart (hSTC810) combined with capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A phase 1b clinical trial.

18 with high-grade colon and appendiceal cancer with peritoneal metastasis, and with 13 oligo-metastatic colon cancer. The funding for this investigator-initiated trial was provided by the KU ...